MMCM
MDLN

Murphy & Mullick Capital Management’s Medline Inc MDLN Stock Holding History

Murphy & Mullick Capital Management’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.8K Hold
375
– – 0.01% 451
2026
Q1 		$16.7K Buy
+375
New +$16.6K 0.01% 412

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Murphy & Mullick Capital Management's MDLN Position: Q2 2026 in Review

Murphy & Mullick Capital Management held its Medline Inc (MDLN) position steady in Q2 2026 at 375 shares worth $14.8K. The position accounts for 0.01% of the portfolio, ranked #451.

Murphy & Mullick Capital Management first reported a position in MDLN in Q1 2026 and has held it in 2 quarters since. The position peaked at $16.7K in Q1 2026. 407 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • Murphy & Mullick Capital Management held 375 shares of Medline Inc worth $14.8K as of Q2 2026.
  • Murphy & Mullick Capital Management left its Medline Inc share count unchanged in Q2 2026.
  • Medline Inc made up 0.01% of Murphy & Mullick Capital Management's portfolio in Q2 2026, its #451 holding.
  • Murphy & Mullick Capital Management first reported a position in Medline Inc in Q1 2026 and has held it in 2 quarters since.
  • Murphy & Mullick Capital Management's Medline Inc position peaked at $16.7K in Q1 2026.
  • 407 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.